Paid Clinical Trials in Livingston, NJ
As of August 2026, 60 paid clinical trials are recruiting in Livingston, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Livingston offers studies at sites including Cooperman Barnabas Medical Center for conditions such as Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia, Myelodysplasia-Related. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Livingston
Trials by drug in Livingston
Filter results
53 clinical trials
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Non-Invasive Preeclampsia Screening and Biobank
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RADA16 for Adult Tonsillectomy
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
ATATcH Alternating Treatment Plans for Advanced Cancer
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Top Research Study Locations in Livingston
Researchers run research studies in Livingston, NJ at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cooperman Barnabas Medical Center | Muscle Invasive Bladder Urothelial Carcinoma, Postoperative Pain, Acute Myeloid Leukemia | 23 |
| Saint Barnabas Medical Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 16 |
| Cooperman Barnabas Medical Center (Saint Barnabas Medical Center) | Colon Cancer, Pancreatic Ductal Adenocarcinoma, Rectal Cancer | 2 |
| Inst of Neurology | Focal Epilepsy | 2 |
| Institute of Neurology and Neurosurgery at Saint Barnabas, LLC | Developmental and Epileptic Encephalopathy, Dravet Syndrome | 2 |
| RWJBarnabas Health - Saint Barnabas Medical Center | Head and Neck Cancer, Lung Cancer, Metastases, Neoplasm | 2 |
| Cooperman Barnabus Medical Center | Renal Transplant Failure and Rejection | 1 |
| Jersey City Medical Center, Inc | Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures | 1 |
| Local Institution - 0059 | Agitation, Alzheimer Disease | 1 |
| New Jersey Perinatal Associates | Preeclampsia (PE) | 1 |
| RWJ Barnabas Health | Multiple Sclerosis | 1 |
| RWJ Barnabas Outpatient Geriatric Clinics | Anxiety, Caregiver Stress Syndrome | 1 |
| RWJBarnabas Health - Cooperman Barnabas, Livingston | HER2-Negative Breast Cancer, Hormone Receptor-Positive Breast Cancer | 1 |
| Robert Wood Johnson Health Network Barnabas Health | Cytomegalovirus (CMV), Kidney Diseases, Kidney Transplant; Complications | 1 |
| Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) | Breast Neoplasms | 1 |
| Saint Barnabas Medical Center Livingston | Periprosthetic Fracture Around Prosthetic Joint Implant, Periprosthetic Fractures | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
Active & Upcoming Studies in Livingston (2026)
Recruiting trials in Livingston grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (32 active studies)
- Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · Phase 2 · National Cancer Institute (NCI)
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (8 active studies)
- Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children · Phase 2 · Rutgers, The State University of New Jersey
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
Mental health & behavior (1 active study)
- mHealth Mindfulness With Patients With Serious Illness and Their Caregivers · Rutgers, The State University of New Jersey
Cardiovascular (1 active study)
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Common conditions studied in Livingston
- Acute Myeloid Leukemia (5 active studies)
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2 active studies)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (2 active studies)
- Acute Myeloid Leukemia, Myelodysplasia-Related (2 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Breast Cancer (2 active studies)
Leading research sponsors in Livingston
- National Cancer Institute (NCI)
- Rutgers, The State University of New Jersey
- NRG Oncology
- Alexion Pharmaceuticals, Inc.
- Biohaven Therapeutics Ltd.
Frequently asked questions
How many paid clinical trials are currently recruiting in Livingston?
There are approximately 60 recruiting clinical trials in Livingston, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Livingston pay participants?
Most recruiting trials in Livingston compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Livingston?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Livingston?
The most common conditions under active study in Livingston include Acute Myeloid Leukemia (5), Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2), Acute Myeloid Leukemia Post Cytotoxic Therapy (2), Acute Myeloid Leukemia, Myelodysplasia-Related (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Livingston?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Livingston on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Livingston?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Livingston?
Recruiting research sites in Livingston include Cooperman Barnabas Medical Center, Saint Barnabas Medical Center, Cooperman Barnabas Medical Center (Saint Barnabas Medical Center), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Livingston right now?
The largest active categories in Livingston are Cancer & tumors (32), Neurology & pain (8), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.